These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 11358830

  • 1. Organ-specific activation of activator protein-1 in transgenic mice by 12-o-tetradecanoylphorbol-13-acetate with different administration methods.
    Zhong S, Quealy JA, Bode AM, Nomura M, Kaji A, Ma WY, Dong Z.
    Cancer Res; 2001 May 15; 61(10):4084-91. PubMed ID: 11358830
    [Abstract] [Full Text] [Related]

  • 2. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS, Kim SH, Song YS, Surh YJ.
    Carcinogenesis; 2004 May 15; 25(5):713-22. PubMed ID: 14729583
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 4. Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway.
    Lin S, Li JJ, Fujii M, Hou DX.
    Int J Oncol; 2003 Apr 01; 22(4):829-33. PubMed ID: 12632075
    [Abstract] [Full Text] [Related]

  • 5. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y, Kang UG, Kim YS, Kim WH, Park SC, Park JB.
    Cancer Res; 2000 Sep 15; 60(18):5067-73. PubMed ID: 11016630
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.
    Zhao Y, Xue Y, Oberley TD, Kiningham KK, Lin SM, Yen HC, Majima H, Hines J, St Clair D.
    Cancer Res; 2001 Aug 15; 61(16):6082-8. PubMed ID: 11507057
    [Abstract] [Full Text] [Related]

  • 7. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.
    Mol Carcinog; 2006 Jan 15; 45(1):26-37. PubMed ID: 16267831
    [Abstract] [Full Text] [Related]

  • 8. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling.
    Shrotriya S, Kundu JK, Na HK, Surh YJ.
    Cancer Res; 2010 Mar 01; 70(5):1932-40. PubMed ID: 20179211
    [Abstract] [Full Text] [Related]

  • 9. Asbestos induces activator protein-1 transactivation in transgenic mice.
    Ding M, Dong Z, Chen F, Pack D, Ma WY, Ye J, Shi X, Castranova V, Vallyathan V.
    Cancer Res; 1999 Apr 15; 59(8):1884-9. PubMed ID: 10213496
    [Abstract] [Full Text] [Related]

  • 10. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate.
    She QB, Chen N, Bode AM, Flavell RA, Dong Z.
    Cancer Res; 2002 Mar 01; 62(5):1343-8. PubMed ID: 11888903
    [Abstract] [Full Text] [Related]

  • 11. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W, Liao QY, Hantash FM, Sanders BG, Kline K.
    Cancer Res; 2001 Sep 01; 61(17):6569-76. PubMed ID: 11522656
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
    Medeiros R, Otuki MF, Avellar MC, Calixto JB.
    Eur J Pharmacol; 2007 Mar 22; 559(2-3):227-35. PubMed ID: 17258194
    [Abstract] [Full Text] [Related]

  • 13. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J, Ma C, Huang Y, Luo J, Huang C.
    Oncogene; 2003 Jan 16; 22(2):211-9. PubMed ID: 12527890
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
    Li JJ, Dong Z, Dawson MI, Colburn NH.
    Cancer Res; 1996 Feb 01; 56(3):483-9. PubMed ID: 8564958
    [Abstract] [Full Text] [Related]

  • 15. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A, Hu J, Reeves R, Resar LM, Colburn NH.
    Oncogene; 2004 May 27; 23(25):4466-76. PubMed ID: 15064752
    [Abstract] [Full Text] [Related]

  • 16. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.
    Liu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z.
    Cancer Res; 2001 Aug 01; 61(15):5749-56. PubMed ID: 11479211
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of atypical PKC blocks ultraviolet-induced AP-1 activation by specifically inhibiting ERKs activation.
    Huang C, Li J, Chen N, Ma W, Bowden GT, Dong Z.
    Mol Carcinog; 2000 Feb 01; 27(2):65-75. PubMed ID: 10657899
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice.
    Lai CS, Li S, Chai CY, Lo CY, Ho CT, Wang YJ, Pan MH.
    Carcinogenesis; 2007 Dec 01; 28(12):2581-8. PubMed ID: 17962218
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB.
    Huang Q, Shen HM, Ong CN.
    Biochem Pharmacol; 2004 Jul 15; 68(2):361-71. PubMed ID: 15194008
    [Abstract] [Full Text] [Related]

  • 20. Correlation between EGFR Y1068 tyrosine phosphorylation and AP-1 activation by tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin.
    Cichocki M, Szamałek M, Dałek M, Baer-Dubowska W.
    Environ Toxicol Pharmacol; 2012 Jan 15; 33(1):92-7. PubMed ID: 22196048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.